Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine on Gut Microbiome in Healthy Volunteers and Colorectal Adenoma Patients
NCT07519681Not yet recruiting
- Sponsor
- Jing-yuan Fang
- Start
- May 2026
- Primary completion
- Sep 2026
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of berberine in Colorectal Adenoma (CRA), sponsored by Jing-yuan Fang. Primary endpoint: Relative abundance of Akkermansia in fecal samples at 2 weeks. Planned start May 2026; status: not yet recruiting.
02
Drugs
berberine
03
Conditions
Colorectal Adenoma (CRA)
Beyond the preview
Go deeper on NCT07519681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07519681.